Druggio Logo

Druggio

Boehringer Ingelheim

Boehringer Ingelheim is a pharmaceutical company that was founded in 1885. It focuses on developing medications for a range of diseases including respiratory, cardiovascular, immune system, and central nervous system disorders. The company's drugs include treatments for conditions such as pulmonary fibrosis, diabetes, stroke prevention, and epilepsy. Boehringer Ingelheim has a reputation for its research and development efforts in innovative drug discovery and therapy improvement.

Boehringer Ingelheim's Drugs

Prizbind

Approval date

2016/9/28

Jardiance

Approval date

2014/12/26

Giotrif

Approval date

2014/1/17

Trazenta

Approval date

2011/7/1

Prazaxa

Approval date

2011/1/21

Micardis

Approval date

2002/10/8

Mobic

Approval date

2000/12/22